New peer-reviewed, scientific study shows Vyleesi enhances sexual brain processing in premenopausal women with HSDD. Click here to learn more ›

November 2015

Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2016 Results; Teleconference and Webcast to be held on November 12, 2015

Press Releases / By

Palatin Technologies Reconnect Study Logo CRANBURY, N.J., Nov. 12, 2015 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced results for its first quarter ended September 30, 2015.  Recent Highlights Bremelanotide development for Female …

Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2016 Results; Teleconference and Webcast to be held on November 12, 2015 Read More »

Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2016 Results; Teleconference and Webcast to be held on November 12, 2015

Press Releases / By

CRANBURY, N.J., Nov. 10, 2015 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its first quarter, fiscal year 2016 operating results on Thursday, November 12, 2015 before the open of the U.S. financial markets. Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November …

Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2016 Results; Teleconference and Webcast to be held on November 12, 2015 Read More »

Scroll to Top